| LINE ITEM (USD / %) | FY 2025
FILED 2025-10-03 | FY 2024
FILED 2024-09-27 | FY 2023
FILED 2023-09-29 |
|---|---|---|---|
| Revenue (Total Sales) | $844.6M | $811.0M | $893.4M |
| YoY Revenue Growth % | +4.1% | -9.2% | — |
| Gross Profit | $290.5M | $256.9M | — |
| Gross Margin % | 34.4% | 31.7% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$27.8M | $32.1M | $77.1M |
| Operating Margin % | -3.3% | 4.0% | 8.6% |
| Net Income (GAAP) | -$70.3M | -$48.8M | $47.4M |
| EBITDA (Normalized) | -$9.5M | $53.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $41.7M | $47.3M | $108.4M |
| Capital Expenditures (CapEx) | $22.9M | $26.9M | — |
| Free Cash Flow (FCF) | $18.8M | $20.4M | $108.4M |
| FCF Margin % | 2.2% | 2.5% | 12.1% |
| Return on Invested Capital (ROIC %) | -3.0% | 2.7% | — |
| Cash & Short-Term Equivalents | $119.5M | $176.0M | — |
| Total Debt (Short + Long Term) | $366.2M | $565.6M | — |
| Total Stockholders' Equity | $476.9M | $540.2M | — |